To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Endocrine disruptors are exogenous substances that act like hormones in the endocrine system and disrupt the physiologic function of endogenous hormones. Studies have linked endocrine disruptors to adverse biological effects in animals, giving rise to concerns that low-level exposure might cause similar effects in human beings.
Additional recommended knowledge
Since the publication of Rachel Carson’s Silent Spring (Carson, 1962), there has been concern that chemicals in the environment might exert profound and deleterious effects on wildlife populations, and that human health is inextricably linked to the health of the environment.
Although researchers had studied the endocrine effects of chemicals in the past, the term endocrine disruptor was coined in 1991 at a conference at the Wingspread Conference Center in Racine, Wisconsin. This conference was chaired by Theo Colburn, then with the World Wildlife Fund and the W. Alton Jones Foundation. The term was introduced into the scientific literature with her 1993 paper. In this paper, she stated that environmental chemicals disrupt the development of the endocrine system, and that effects of exposure during development are permanent.
Endocrine disrupting compounds encompass a variety of chemical classes, including hormones, plant constituents, pesticides, compounds used in the plastics industry and in consumer products, and other industrial by-products and pollutants. Some are pervasive and widely dispersed in the environment. Some are referred to as persistent organic pollutants (POP's), and can be transported long distances across national boundaries, which have been found in virtually all regions of the world. Others are rapidly degraded in the environment or human body or may be present for only short periods of time.
Health effects attributed to endocrine disrupting compounds include a range of reproductive problems (reduced fertility, male and female reproductive tract abnormalities, and skewed male/female sex ratios, loss of fetus, menstrual problems, changes in hormone levels; early puberty; brain and behavior problems; impaired immune functions; and various cancers.
One example of the consequences of the exposure of developing animals, including humans, to hormonally active agents is the case of the drug diethylstilbestrol (DES), a non-steroidal estrogen. Prior to its ban in the early 1970's, doctors prescribed DES to as many as five million pregnant women to block spontaneous abortion, an Off-label use of this medication prior to 1947. It was discovered after the children went through puberty that DES affected the development of the reproductive system and caused vaginal cancer. The relevance of the DES saga to the risks of exposure to endocrine disruptors is questionable, as the doses involved are much lower than those due to environmental exposures.
The endocrine system
Hormones are released by glands and travel throughout the body, acting as chemical messengers. Hormones interface with cells that contain matching receptors in or on their surfaces. The hormone binds with the receptor, much like a key would fit into a lock.
The Theory of Endocrine disruption
Altering hormone signals can change how the body works and may lead to health problems. Some people speculate that endocrine disrupting compounds may be linked to many health concerns, such as cancer, diabetes, obesity, learning disabilities and behavioural problems. Solid human evidence linking EDCs with these kinds of effects is hard to determine, but their is increasing evidence from the fields of epidemiology, toxicology, environmental health, and environmental science that suggests there might be something to the claims.
There are now hundreds of studies of cell cultures, laboratory animals, wildlife, and accidentally exposed humans that demonstrate how EDC's cause a wide range of reproductive, developmental, growth, and behavior problems. The most attention has been given to those compounds that produce estrogenic, androgenic, antiandrogenic, and antithyroid actions. Less is known about interactions with other hormones and possible effects on immunity (infections), metabolism, (obesity), the brain (intelligence, behavior), the heart, the lungs, and multiple generations.
The interrelationship between exposures to chemicals and health effects are rather complex and multifactoral and occur along a continuum. It is often hard to definitively link a particular chemical with a specific health effect, and exposed adults may not show any ill effects. But, fetuses and embryos, whose growth and development are highly controlled by the endocrine system, are more vulnerable to exposure and may suffer overt or subtle lifelong health and/or reproductive abnormalities (Bern 1992). Prebirth exposure, in some cases, can lead to permanent alterations and adult diseases.
Increasingly, study is being focused on prenatal exposure in the first trimester as the most significant point of contamination.[attribution needed]
For example, testicular cancer in young men takes root before birth during fetal development. Certain cancers and uterine abnormalities in women are associated with exposure to DES in the womb. In another case, phthalates in pregnant women’s urine was liked to subtle, but specific, genital changes in their male infants – a shorter, more female-like anal-genital distance and associated incomplete descent of testes and a smaller scrotum and penis.  The ubiquitous compounds, found in plastics and cosmetics, are known to block the androgens that control development of the normally longer male anal-genital distance.
Scientific Objection to the Theory
One major objection to the theory of endocrine disruptors is the dosage effect. There is a large gap between high exposures seen in a laboratory experiment versus the relatively low levels found in the environment. 
The theory has been applied inappropriately, leading to delays in recognizing environmental problems with other causes. For example, a worldwide decline in amphibians has been attributed to endocrine disruptors, but there is evidence that this is largely due to infectious diseases.
The term endocrine disruptor has been applied to the effects of DDT or its metabolite DDE on eggshells, but there is no evidence that this is caused by any endocrine mechanism. The effect may be due to enzyme inhibition. The term has been applied to other chemicals, without scientific proof that they have an endocrine effect.
Thre are philosophical objections to the term endocrine disruptor based on the logical principals of begging the question and fallacies of definition, as it is not proven that these chemicals disrupt the endocrine system, at least in the concentrations in which they are found in the environment.  For that reason, some scientists prefer the less emotionally laden term HAA (for Hormonally Active Agent).
Types of Endocrine Disruptors
All people are exposed to chemicals with estrogenic effects in their everyday life, because endocrine disrupting chemicals are found in low doses in literally thousands of products. Among the most commonly encountered are Bisphenol A, Polybrominated diphenyl ethers (PBDE's), and a variety of Phthalates. There is a great deal of dispute in the scientific community surrounding the question. Many believe that there is little evidence that the degree of exposure in humans is enough to warrant concern, , while many others believe there is ample evidence that these chemicals pose at least some risk to human health.
Bisphenol A: This is found in some plastic water and baby bottles, plastic food containers, dental materials, and the linings of metal food cans. Potential health concern: linked to reduced sperm counts. May contribute to miscarriages, obesity and some cancers.
Polybrominated diphenyl ethers: These are found in fire retardants used in plastic cases of televisions and computers, electronics, carpets, lighting, bedding, clothing, car components, foam cushions and other textiles. Potential health concern: PBDE's are structurally very similar to Polychlorinated biphenyls (PCBs), and have similar neurotoxic effects. Have the potential to disrupt thyroid hormone balance and contribute to a variety of neurological and developmental deficits, including low intelligence and learning disabilities. Many of the most common PBDE's were banned in the European Union in 2006.
Phthalates: These are found in some soft toys, flooring, medical equipment, cosmetics and air freshener. Potential health concern: known to disrupt the endocrine system and implicated in feminized genitals of baby boys. Banned in California and Europe. One phthalate, Bis(2-ethylhexyl) phthalate (DEHP), used in medical tubing, catheters and blood bags, may harm sexual development in male infants. In 2002, the Food and Drug Administration released a public report which cautioned against exposing male babies to DEHP. Although there are no direct human studies the FDA report states: "Exposure to DEHP has produced a range of adverse effects in laboratory animals, but of greatest concern are effects on the development of the male reproductive system and production of normal sperm in young animals. We have not received reports of these adverse events in humans, but there have been no studies to rule them out. However, in view of the available animal data, precautions should be taken to limit the exposure of the developing male to DEHP.
Some of the other most well-known examples of EDCs are 17-alpha ethinylestradiol an estrogen found in many oral contraceptives, Dioxins, PCBs, PAHs, furans, phenols and several pesticides (most prominent DDT and its derivatives). Substances with estrogenic effects include the xenoestrogens and phytoestrogens.
The multitude of possible endocrine disruptors are technically regulated in the United States by many laws, including: the Toxic Substances Control Act, the Federal Insecticide, Fungicide, and Rodenticide Act, the Food, Drug and Cosmetic Act, the Clean Water, the Safe Drinking Water Act, and the Clean Air Act.
The Congress of the United States has improved the evaluation and regulation process of drugs and other chemicals. The Food Quality Protection Act of 1996 and the Safe Drinking Water Act of 1996 simultaneously provided the first legislative direction requiring the EPA to address endocrine disruption through establishment of a program for screening and testing of chemical substances.
In 1998 the EPA announced the Endocrine Disruptor Screening Program by establishment of a framework for priority setting, screening and testing more than 85,000 chemicals in commerce. The basic concept behind the program is that prioritization will be based on existing information about chemical uses, production volume, structure-activity and toxicity. Screening is done by use of in vitro test systems (by examining, for instance, if an agent interacts with the estrogen receptor or the androgen receptor) and via the use of in animal models, such as development of tadpoles and uterine growth in prepubertal rodents. Full scale testing will examine effects not only in mammals (rats) but also in a number of other species (frogs, fish, birds and invertebrates).
After failing to meet several deadlines to begin testing, the EPA finally announced that they were ready to begin the process of testing dozens of high production volume chemicals that are known endocrine disruptors early in 2007, eleven years after the program was announced. Unfortunately, when the final structure of the tests was announced there was widespread dismay at their design. Critics have charged that the entire process has been compromised by chemical company interference. . In 2005, the EPA appointed a panel of experts to conduct an open peer-review of the program and its orientation. Their results found that "the long-term goals and science questions in the EDC program are appropriate"., however this study was conducted over a year before the EPA announced the final structure of the screening program.
Colborn, Theo; Dianne Dumanoski; and John Peterson Myers. Our stolen future : are we threatening our fertility, intelligence, and survival? : a scientific detective story. New York : Dutton, 1996. 306 p. ISBN 0452274141
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Endocrine_disruptor". A list of authors is available in Wikipedia.|